Cargando…

Does lopinavir really inhibit SARS-CoV-2?

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Cattaneo, Dario, Gervasoni, Cristina, Corbellino, Mario, Galli, Massimo, Riva, Agostino, Clementi, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211645/ https://www.ncbi.nlm.nih.gov/pubmed/32438034 http://dx.doi.org/10.1016/j.phrs.2020.104898

Ejemplares similares

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
por: Cattaneo, Dario, et al.
Publicado: (2020)

Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
por: Cattaneo, Dario, et al.
Publicado: (2021)

Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events
por: Gervasoni, Cristina, et al.
Publicado: (2013)

Darunavir does not prevent SARS-CoV-2 infection in HIV patients
por: Riva, Agostino, et al.
Publicado: (2020)

Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?
por: Gervasoni, Cristina, et al.
Publicado: (2015)

The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
por: Cattaneo, Dario, et al.
Publicado: (2022)

Multidrug-resistant HIV viral rebound during early syphilis: a case report
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Development of an HPLC–UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients()
por: Charbe, Nitin, et al.
Publicado: (2016)

Clinical and genetic determinants of nevirapine plasma trough concentration
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
por: Cheli, Stefania, et al.
Publicado: (2023)

Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis
por: Antoniazzi, Stefania, et al.
Publicado: (2012)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
por: Cattaneo, Dario, et al.
Publicado: (2020)

Management of diabetes mellitus in people living with HIV: A single-center experience
por: Cattaneo, Dario, et al.
Publicado: (2023)

Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects
por: Carnovale, Carla, et al.
Publicado: (2022)

Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out
por: Tagliabue, Mario, et al.
Publicado: (2021)

A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy
por: Sciorati, Clara, et al.
Publicado: (2011)

Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine
por: Pogliani, Laura, et al.
Publicado: (2012)

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
por: Cossu, Maria Vittoria, et al.
Publicado: (2014)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
por: Cattaneo, Dario, et al.
Publicado: (2023)

Abacavir-induced liver toxicity
por: Pezzani, Maria Diletta, et al.
Publicado: (2016)

Are Modular Activations Altered in Lower Limb Muscles of Persons with Multiple Sclerosis during Walking? Evidence from Muscle Synergies and Biomechanical Analysis
por: Lencioni, Tiziana, et al.
Publicado: (2016)

Effects of Fatigue on Balance and Mobility in Subjects with Multiple Sclerosis: A Brief Report
por: Gervasoni, Elisa, et al.
Publicado: (2012)

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
por: Montrasio, Cristina, et al.
Publicado: (2023)

Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
por: Tarkowski, Maciej, et al.
Publicado: (2021)

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
por: Cattaneo, Dario, et al.
Publicado: (2020)

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020)

Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials
por: Criscuolo, Elena, et al.
Publicado: (2021)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020
por: Antinori, Spinello, et al.
Publicado: (2021)

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
por: Perrone, Valentina, et al.
Publicado: (2014)

Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2
por: Criscuolo, Elena, et al.
Publicado: (2022)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
por: Corti, Silvia, et al.
Publicado: (2019)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
por: Clementi, Nicola, et al.
Publicado: (2021)

Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic
por: Lai, Alessia, et al.
Publicado: (2020)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2022)

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review
por: Borgonovo, Fabio, et al.
Publicado: (2023)

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients
por: Zanon, D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i7ssq11v3h0ur82s4d7kj13a9d